UY34594A - Derivados heterocíclicos bicíclicos, su preparación y su aplicación en terapéutica - Google Patents

Derivados heterocíclicos bicíclicos, su preparación y su aplicación en terapéutica

Info

Publication number
UY34594A
UY34594A UY0001034594A UY34594A UY34594A UY 34594 A UY34594 A UY 34594A UY 0001034594 A UY0001034594 A UY 0001034594A UY 34594 A UY34594 A UY 34594A UY 34594 A UY34594 A UY 34594A
Authority
UY
Uruguay
Prior art keywords
therapeutics
preparation
application
bicyclic heterocyclic
heterocyclic derivatives
Prior art date
Application number
UY0001034594A
Other languages
English (en)
Inventor
Alain Braun
Yann Foricher
Gilbert Marciniak
Nicolas Muzet
Eric Nicolai
Pascal Cecile
Bertrand Vivet
Fabrice Viviani
Olivier Crespin
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of UY34594A publication Critical patent/UY34594A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invención se refiere a los derivados heterocíclicos bicíclicos, de fórmula general (I) a su procedimiento de preparación y aplicación en terapéutica.
UY0001034594A 2012-01-26 2013-01-25 Derivados heterocíclicos bicíclicos, su preparación y su aplicación en terapéutica UY34594A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1250768A FR2986232B1 (fr) 2012-01-26 2012-01-26 Derives heterocycliques bicycliques, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
UY34594A true UY34594A (es) 2013-09-02

Family

ID=47997597

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034594A UY34594A (es) 2012-01-26 2013-01-25 Derivados heterocíclicos bicíclicos, su preparación y su aplicación en terapéutica

Country Status (26)

Country Link
US (1) US9120812B2 (es)
EP (1) EP2807172B1 (es)
JP (1) JP6068508B2 (es)
KR (1) KR20140125389A (es)
CN (1) CN104203958B (es)
AR (1) AR089782A1 (es)
AU (1) AU2013213261B2 (es)
BR (1) BR112014018226A8 (es)
CA (1) CA2862747A1 (es)
CY (1) CY1118852T1 (es)
DK (1) DK2807172T3 (es)
ES (1) ES2617880T3 (es)
FR (1) FR2986232B1 (es)
HR (1) HRP20170288T1 (es)
HU (1) HUE031917T2 (es)
IL (1) IL233774A (es)
LT (1) LT2807172T (es)
MX (1) MX348841B (es)
PL (1) PL2807172T3 (es)
PT (1) PT2807172T (es)
RU (1) RU2627269C2 (es)
SG (1) SG11201404325VA (es)
SI (1) SI2807172T1 (es)
TW (1) TWI572608B (es)
UY (1) UY34594A (es)
WO (1) WO2013111106A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014336775B2 (en) 2013-10-16 2018-04-05 Shanghai Yingli Pharmaceutical Co., Ltd Fused heterocyclic compound, preparation method therefor, pharmaceutical composition, and uses thereof
WO2016050201A1 (zh) * 2014-09-29 2016-04-07 山东轩竹医药科技有限公司 高选择性取代嘧啶类pi3k抑制剂
US10307707B2 (en) * 2017-05-17 2019-06-04 Thomas P. Daly 1-amino-2-methyl-2-propanol derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1473295B1 (en) * 2002-01-18 2009-04-01 Kyorin Pharmaceutical Co., Ltd. Fused bicyclic pyrimidine derivatives
AU2003293006A1 (en) * 2002-11-22 2004-06-18 Japan Tobacco Inc. Fused bicyclic nitrogen-containing heterocycles
EP2382207B1 (en) * 2008-11-11 2015-04-29 Xcovery Holding Company LLC Pi3k/mtor kinase inhibitors
KR20120087808A (ko) * 2009-05-26 2012-08-07 엑셀리시스, 인코포레이티드 ＰＩ3Ｋ／ｍ ＴＯＲ의 억제제로서의 벤즈옥사제핀 및 이의 사용 및 제조 방법
JP2013529212A (ja) * 2010-05-19 2013-07-18 エクスカバリー ホールディング カンパニー，エルエルシー ｍＴＯＲ選択的キナーゼ阻害剤

Also Published As

Publication number Publication date
SI2807172T1 (sl) 2017-03-31
RU2627269C2 (ru) 2017-08-04
RU2014134640A (ru) 2016-03-27
HRP20170288T1 (hr) 2017-04-21
DK2807172T3 (en) 2017-03-06
ES2617880T3 (es) 2017-06-20
AU2013213261A1 (en) 2014-08-21
CN104203958A (zh) 2014-12-10
BR112014018226A2 (es) 2017-06-20
FR2986232B1 (fr) 2014-02-14
US20140378433A1 (en) 2014-12-25
CY1118852T1 (el) 2018-01-10
JP2015504914A (ja) 2015-02-16
US9120812B2 (en) 2015-09-01
AU2013213261B2 (en) 2017-07-20
AR089782A1 (es) 2014-09-17
FR2986232A1 (fr) 2013-08-02
HUE031917T2 (en) 2017-08-28
EP2807172A1 (en) 2014-12-03
PT2807172T (pt) 2017-03-06
KR20140125389A (ko) 2014-10-28
MX2014009084A (es) 2015-02-05
SG11201404325VA (en) 2014-08-28
WO2013111106A1 (en) 2013-08-01
CN104203958B (zh) 2017-05-31
TW201333016A (zh) 2013-08-16
IL233774A (en) 2016-06-30
TWI572608B (zh) 2017-03-01
MX348841B (es) 2017-06-30
LT2807172T (lt) 2017-03-27
EP2807172B1 (en) 2016-11-30
JP6068508B2 (ja) 2017-01-25
BR112014018226A8 (pt) 2017-07-11
CA2862747A1 (en) 2013-08-01
PL2807172T3 (pl) 2017-05-31

Similar Documents

Publication Publication Date Title
UY34566A (es) 1,4?dihidropirimidinas 4,4?disustituidas y su uso como medicamentos para el tratamiento de la hepatitis b
UY34541A (es) ?derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina?.
CL2016000153A1 (es) Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis b
UY34472A (es) Derivados modificados de 4-fenil-piridina
CL2015001985A1 (es) Compuestos de tiazolcarboxamidas y piridinacarboxamida, inhibidores de quinasa pim.
UY34778A (es) ?COMPUESTOS DE HEXAHIDROPIRANO[3,4-d][1,3]TIAZIN-2-AMINA HETEROCÍCLICOS SUSTITUÍDOS?.
UY34632A (es) Compuestos de oxazolidin- 2- ona y usos de los mismos
UY34763A (es) Inhibidores de la agregación plaquetaria
UY34342A (es) ?derivados de pirrolopirimidina y purina?.
UY34200A (es) 3-(fluorovinil)pirazoles y su uso
UY33970A (es) Derivados de ácido 3-fenilpropiónico ramificados y su uso
UY34643A (es) Derivados de 5-alquinilo piridina como inhibidores de apoptosis,composiciones farmacéuticas y sus usos como miméticos smac
UY34538A (es) Heteroarilos y usos de los mismos
AU343911S (en) Animal garment
UY34610A (es) Pirroldicarboxamidas condensadas y su uso como agentes farmacéuticos.
UY34167A (es) Pirrolotriazinas sustituidas con hidroximetilarilo y sus usos
GT201600014S (es) Motocicleta
GT201400001S (es) Diseño de moto-bicicleta
UY34018A (es) Derivados glucósidos y usos de los mismos
MX2016004802A (es) Anticuerpos anti-r-espondina (anti-rspo) y metodos de uso.
UY34590A (es) Fenilimidazopirazoles sustituidos y su uso
UY34863A (es) Antagonistas de iap
AR092882A1 (es) 1,2,4-triazin-3,5-dion-6-carboxamidas y su uso como herbicidas
GT201400061S (es) Diseño de motocicleta
EA201890439A1 (ru) ИММУНООНКОЛОГИЧЕСКАЯ МЕЗОДЕРМАЛЬНАЯ КЛЕТКА-ПРЕДШЕСТВЕННИК (ioMP-КЛЕТКА)

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20210526